SCHEMBL8140486

SCHEMBL8140486

CCc1nc(-c2cc(F)c(C)cc2Cl)cn1C(CC)COC

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CRHR1 P34998 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8146077 0.87 CRHR1 (0.36) CRHR1
SCHEMBL8145796 0.79 CRHR1 (0.33) CRHR1
SCHEMBL8147374 0.79 CRHR1 (0.32) CRHR1
SCHEMBL8145602 0.77 KMT2A (0.37) CRHR1
SCHEMBL8149046 0.76 TSHR (0.39) CRHR1
SCHEMBL8152169 0.75 CRHR1 (0.39) CRHR1
SCHEMBL8152915 0.74 CRHR1 (0.34) CRHR1
SCHEMBL7030975 0.73
SCHEMBL8145397 0.73 CRHR1 (0.39) CRHR1
SCHEMBL7038547 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994877-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Du Pont Pharmaceuticals Company (US) 2000-04-26 EP disclosed
WO-1999001454-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS DU PONT PHARMACEUTICALS COMPANY (US) 1999-01-14 WO disclosed